Navigation Links
FDA Approves Label Update for PREZISTA® to Include 192-Week Data in HIV-1-Infected Adult Patients Starting Treatment
Date:10/21/2011

jury, including some fatalities, have been reported. A causal relationship with PREZISTA/ritonavir therapy has not been established

Appropriate laboratory testing should be conducted prior to initiating therapy with PREZISTA/ritonavir and patients should be monitored during treatment. Increased AST/ALT monitoring should be considered in patients with underlying chronic hepatitis, cirrhosis, or in patients who have pretreatment elevations of transaminases, especially during the first several months of PREZISTA/ritonavir treatment. Evidence of new or worsening liver dysfunction (including clinically significant elevation of liver enzymes and/or symptoms such as fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly) in patients on PREZISTA/ritonavir should prompt consideration of interruption or discontinuation of treatment

  • Severe Skin Reactions:  Severe skin reactions (0.4%), accompanied by fever and/or elevations of transaminases in some cases, Stevens-Johnson Syndrome (<0.1%), and toxic epidermal necrolysis (post-marketing experience) have been reported in patients receiving PREZISTA/ritonavir.  Discontinue PREZISTA/ritonavir immediately if signs or symptoms of severe skin reactions develop (including, but not limited to, severe rash or rash accompanied with fever, general malaise, fatigue, muscle or join aches, blisters, oral lesions, conjunctivitis, hepatitis and/or eosinophilia).

  • In clinical trials (N=3063), rash (all grades, generally mild to moderate, regardless of causality) occurred in 10.3% of patients receiving PREZISTA/ritonavir. Discontinuation due to rash was 0.5%

  • Sulfa Allergy: PREZISTA should be used with caution in patients with known sulfonamide allergy
  • Diabetes Mellitus/Hyperglycemia and Hemophilia: New-onset or exacerbations of preexisting diabetes mellitus, hyperglycemia, and increased bleeding in hemophiliacs have been reported in patients re
    '/>"/>

  • SOURCE Janssen Therapeutics, Division of Janssen Products, LP
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body
    2. FDA Approves Combination Therapy Juvisync
    3. FDA Approves Cialis to Treat Benign Prostatic Hyperplasia
    4. FDA Approves Remicade to Treat Ulcerative Colitis in Children Older Than 6 Years
    5. FDA Approves Soliris for Rare Pediatric Blood Disorder
    6. FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
    7. FDA Approves Xalkori with Companion Diagnostic for a Type of Late-stage Lung Cancer
    8. FDA Approves Firazyr To Treat Acute Attacks of Hereditary Angioedema
    9. FDA Approves Adcetris to Treat Two Types of Lymphoma
    10. FDA Approves the First Specific Treatment for Scorpion Stings
    11. Cardinal Health Board of Directors Approves Cash Dividend, Elects David P. King as Director
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/23/2015)... 23, 2015 Surna, Inc. (OTCQB: SRNA), a ... art equipment and systems for controlled environment agriculture ... cultivation, will host a shareholder conference call to ... at 4:15 PM Eastern Standard Time/1:15 PM Pacific ... will be listen-in only, but will include a ...
    (Date:4/23/2015)... 2015 WellStar Health System continues to raise ... with the most advanced technology. WellStar Kennestone Hospital is ... to offer TomoTherapy and one of only two ... offer both TomoTherapy and CyberKnife, another leading cancer treatment. ... around the patient, which allows radiation to be delivered ...
    (Date:4/23/2015)... 2015  Hill-Rom Holdings, Inc., (NYSE: HRC ) ... the Deutsche Bank 40 th Annual Health Care ... You are invited to listen to the ... or access it directly at http://edge.media-server.com/m/p/yvym8uoy . ... one hour after conclusion of the live event and ...
    Breaking Medicine Technology:Surna, Inc. Announces Shareholder Conference Call 2Surna, Inc. Announces Shareholder Conference Call 3WellStar's New, Highly Targeted Therapy Shortens Cancer Treatment Time 2
    ... 2012 Glaucoma is the second leading cause of ... market with a significant opportunity to fulfill unmet medical ... glaucoma will expand as the population ages. ... Analysis of the United States Glaucoma Pharmaceuticals Market ...
    ... Shire plc (LSE: SHP, NASDAQ: SHPGY ... three months to March 31, 2012. Financial ... revenues million +21% Non GAAP operating income $362 million +18% ... earnings per ADS $1.48 +20% US GAAP diluted earnings per ...
    Cached Medicine Technology:Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan 2Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan 3Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 2Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 3Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 4Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 5Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 6Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 7Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 8Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 9Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 10Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 11Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 12Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 13Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 14Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 15Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 16Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 17Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 18Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 19Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 20Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 21Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 22Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 23Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 24Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth 25
    (Date:4/25/2015)... Carinsurancequotesinfo.com has released a new blog post that explains ... for flatbed trucks. , Flatbed trucks are used ... are mainly used for commercial purposes and thus require ... that by comparing multiple offers, drivers can find low ... , It is now possible to compare free online ...
    (Date:4/25/2015)... Gardant Management Solutions will lead sessions ... and sales and marketing at the LeadingAge Illinois ... held from April 29 through May 1 in ... eldercare association in Illinois. The statewide association represents ... including senior housing, assisted living and supportive living ...
    (Date:4/25/2015)... On Friday, April 17, Interstate Batteries was ... Implementation Award. This award is given to the ... RFID technology to improve its manufacturing, supply chain or ... demonstrates how RFID is delivering real value to shareholders. ... 2015 in San Diego, the RFID industries annual trade ...
    (Date:4/24/2015)... Multi Customer Discount , Rules: This ... http://www.zeitersseptics.com/multi-customer-discount.html ) of 1000-1500 gallons in Zeiter's Septics service ... does not include any Dig fees, or any other ... If someone is part of this group event and ... 2500 gallons or more, the cost would be $300.00. ...
    (Date:4/24/2015)... Houston, TX (PRWEB) April 24, 2015 The ... Dan Long, after their great success of the Xtreme Fat ... the industry. The fat loss blueprint that claims to ... caught the attention of HealthyandFitZone.com's Stan Stevenson, prompting an investigative ... shows that the creators spent years researching and experimenting ...
    Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes for Flatbed Trucks Available Online! 2Health News:Gardant Management Solutions Staff Shares Operational Expertise 2Health News:Seeonic’s Industry Leading Technology Powers Interstate Batteries to Winning Award 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 3Health News:Fastest Fat Loss Week Ever Review Revealed on Healthy & Fit Zone 2
    ... executive, has warned that acute hospitals and Action and Emergency (A&E) ... health services deficit of ?512million. He added that ... may be combined in fewer units. ,He pointed out ... have to be maintained along with ...
    ... Tshwane University of Technology (TUT) have recommended shopping till ... not revenge on your husband or even your bank ... ,Department of sport and physical rehabilitation sciences ... the group of 40 students stumbled upon this finding ...
    ... has claimed 49 lives and affected 20,000 people in West ... Das told the West Bengal Assembly today. // ... as those of malignant malaria, Das said during mention hour., ... he said that it was far from adequate. Besides, there ...
    ... (INSH) ASHVINI located in Mumbai has been named the best ... ,Defence Minister Pranab Mukherjee awarded the Running trophy and a ... the hospital, Rear Admiral V K Saxena here today., ... functioning hospital among the Command Hospitals of the Indian Army ...
    ... moghul and UN Messenger for Peace, Vijay Amritraj, has ... India among HIV/AIDS victims. // ,The UN ... HIV/AIDS in India and only a fraction is getting ... medicines for the disease., ,Launching the `Amritraj Foundation' ...
    ... levels of benzene in two diet drinks, which has ... market. , ,The two drinks that have been ... Rose's Diabetic Squash Concentrate. Stricter guidelines have been enabled ... benzene formation in the drinks., ,Benzene, a ...
    Cached Medicine News:
    The only solution for in-line digital measurement...
    ... dedicated system for non-invasive ... (SRS/SRT), represents cutting-edge technology ... of brain as well ... tumors, arteriovenous malformations and ...
    Clinac Platinum Plus accelerators offer all the high performance features of the EX series and come with the latest high-precision dose sculpting technology for advanced tumor control....
    ... accelerators are true high-performance ... multileaf collimation and electronic ... enable you to perform ... IMRT treatments, as well ...
    Medicine Products: